Cadila Healthcare Moraiya plant gets USFDA warning letter for significant violations of CGMP Medical Dialogues Bureau16 Nov 2019 11:11 AM ISTCadila Healthcare failed to clean, maintain, and, as appropriate for the nature of the drug, sanitize and/or sterilise equipment and utensils at...
Cadila Healthcare largest API manufacturing site clears USFDA inspection Medical Dialogues Bureau12 Oct 2019 11:41 AM ISTThe US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
Hetero Labs recalls over 15.90 lakh bottles of hypertension drug from US Ruby Khatun Khatun30 Aug 2018 11:26 AM ISTNew Delhi: Drug firm Hetero Labs is recalling over 15.90 lakh bottles of Valsartan Tablets used for the treatment of hypertension from the American...
DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns Medical Dialogues Bureau9 Feb 2018 11:28 AM ISTHYDERABAD: Dr. Reddy's Laboratories has initiated a voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and...
Lupin gets warning letter from USFDA for Goa, Indore plants Ruby Khatun Khatun17 Nov 2017 11:00 AM ISTNew Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Lupin for violation of current good manufacturing practice norms...
Lupins US arm recalls 12,888 bottles of ulcer drug in US Ruby Khatun Khatun14 Sept 2017 10:02 AM ISTNew Delhi: Drug firm Lupin's US arm, Lupin Pharmaceuticals Inc, is recalling 12,888 bottles of Famotidine for oral suspension used in the treatment of...
